← Eichor
Condition: Chronic Obstructive Pulmonary Disease Severe Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Chronic Obstructive Pulmonary Disease Severe

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study
Phase N/A · 1 location(s) · Brigham and Women's Hospital · NCT01177618Treatment of Chronic Obstructive Pulmonary Disease by Infusion of Allogenic Mesenchymal Stem Cells
Phase 2 · 2 location(s) · Meribank Biotech Co., Ltd. · NCT06491043Effect of HIgh-flow Therapy in Long-term Oxygen Therapy
NA · 2 location(s) · Skane University Hospital · NCT06247397Trial Evaluating the Rate of Pneumothorax in Severe Emphysema Secondary to Endoscopic Volume Reduction With Two-stage ZE
NA · 17 location(s) · University Hospital, Limoges · NCT06181357STRIVE Post-Market Registry Study
Phase N/A · 14 location(s) · Olympus Corporation of the Americas · NCT04302272A Multi Center Study Testing a New Implant for Adults With Severe Emphysema
NA · 3 location(s) · Pulmair Medical, Inc. · NCT07119229A Multi-center RCT to Evaluate Subsegmental BTVA Treatment for Severe Emphysema
NA · 9 location(s) · Shanghai Chest Hospital · NCT06152107Study of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Trixeo
Phase N/A · 36 location(s) · AstraZeneca · NCT07069829A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D
Phase 3 · 301 location(s) · AstraZeneca · NCT06883305Post-marketing Phase 4 Safety & Tolerability Study of Breztri aerosphereTM in Indian Patients With Chronic Obstructive P
Phase 4 · 5 location(s) · AstraZeneca · NCT06531798A Trial of the Implantable Artificial Bronchus 50 Flex in Patients With Severe Emphysema
NA · 2 location(s) · Pulmair Medical, Inc. · NCT07086339Acute Effect of Different Frequency of Whole Body Vibration (WBV) on Healthy and Chronic Obstructive Pulmonary Disease (
NA · 1 location(s) · National Cheng Kung University · NCT07509606Deployment o the Multidisciplinary Prospective Cohort Imminent
NA · 1 location(s) · University Hospital, Lille · NCT04334031Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and T
Phase 3 · 159 location(s) · GlaxoSmithKline · NCT06961214Prospective and Multicentric Cohort Study of Severe and Very Severe Chronic Obstructive Pulmonary Disease (COPD) in Braz
Phase N/A · 1 location(s) · Hospital Israelita Albert Einstein · NCT06724315Respiratory and Cardiovascular Alterations in Patients With Chronic Obstructive Pulmonary Disease
Phase N/A · 1 location(s) · Lithuanian University of Health Sciences · NCT06072690A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease
Phase 2 · 12 location(s) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06300320An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
NA · 36 location(s) · Pulmonx Corporation · NCT06035120A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmo
Phase 2/Phase 3 · 103 location(s) · Pfizer · NCT07363694Eosinopenia in Severe COPD Exacerbation
Phase N/A · 1 location(s) · Northumbria Healthcare NHS Foundation Trust · NCT06188065A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
Phase 2 · 4 location(s) · Windward Bio · NCT07646587Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury
Phase 2 · 2 location(s) · Hope Biosciences LLC · NCT05951777A Phase II Study of CM326 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Phase 2 · 1 location(s) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · NCT07418736Study That Will Evaluate the Brazilian Population With COPD.
Phase N/A · 10 location(s) · AstraZeneca · NCT06780046Unilateral vs. Bilateral Lung Volume Reduction Surgery
NA · 1 location(s) · Rigshospitalet, Denmark · NCT07731958Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Muco-Obstructive Lung Disease
Phase N/A · 1 location(s) · University of Kansas Medical Center · NCT06985225A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D
Phase 3 · 268 location(s) · AstraZeneca · NCT06878261Reducing Breathlessness With Dronabinol in COPD Patients
Phase 3 · 1 location(s) · Vejle Hospital · NCT06473701Effect of IMT in Patients After Acute Exacerbations of COPD
NA · 12 location(s) · KU Leuven · NCT07213128Phase II Study of RC1416 Injection in COPD
Phase 2 · 42 location(s) · Nanjing RegeneCore Biotech Co., Ltd. · NCT07402551
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.